Skip to product information
1 of 2

AMBRA1 Recombinant Rabbit mAb (S-5270-63)

AMBRA1 Recombinant Rabbit mAb (S-5270-63)

Catalog Number: S0B60811 Application: WB Reactivity: Hu, Mk Conjugation: Unconjugated Brand: Starter
Price:
Regular price $100 USD
Regular price Sale price $100 USD
Size:

For shipping services or bulk orders, you may request a quotation.
Secure checkout with
View full details

Product Details

Product Specification


Host Rabbit
Antigen AMBRA1
Synonyms Activating molecule in BECN1-regulated autophagy protein 1; DCAF3; KIAA1736
Immunogen Synthetic Peptide
Location Cytoplasm, Cytoskeleton, Nucleus, Mitochondrion, Endoplasmic reticulum
Accession Q9C0C7
Clone Number S-5270-63
Antibody Type Recombinant mAb
Isotype IgG
Application WB
Reactivity Hu, Mk
Positive Sample A-673, PANC-1, HDLM-2, COS-7
Purification Protein A
Concentration 0.5 mg/ml
Conjugation Unconjugated
Physical Appearance Liquid
Storage Buffer

PBS, 40% Glycerol, 0.05% BSA, 0.02% sodium azide

Stability & Storage

12 months from date of receipt / reconstitution, -20 °C as supplied

Dilution


application dilution species
WB 1:1000 Hu, Mk

Background

AMBRA1 (activating molecule in Beclin 1-regulated autophagy 1) is a highly intrinsically disordered scaffold protein whose distinctive feature is the simultaneous regulation of two core machineries: cell proliferation and autophagy. In autophagy regulation, AMBRA1 acts as a positive regulator of Beclin 1 in autophagosome formation and can also function as a mitophagy receptor, binding LC3 through an LIR motif to induce mitochondrial clearance independently of the PARKIN/p62 pathway. In cell cycle regulation, AMBRA1 serves as a substrate receptor for the CRL4^DDB1^ E3 ubiquitin ligase, recognizing and promoting the ubiquitination and degradation of D-type cyclins (Cyclin D1/D2/D3), thereby inhibiting S-phase entry and exerting tumor-suppressive function. Structural studies have revealed that the N-terminal helix-loop-helix motif of AMBRA1 cooperates with a "split" WD40 domain to bind DDB1, forming a substrate-recruitment scaffold. At the pathological level, loss of AMBRA1 function is associated with multiple diseases: its mutations can impair autophagic clearance of free α-globin by erythroid cells, aggravating the β-thalassemia phenotype; in melanoma, AMBRA1 loss alters the tumor immune microenvironment and affects the efficacy of PD-1 inhibitors; moreover, by regulating the balance between apoptosis and autophagy, AMBRA1 has also emerged as a potential therapeutic target for neurodegenerative diseases.

Picture

Western Blot

WB result of AMBRA1 Recombinant Rabbit mAb
Primary antibody: AMBRA1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: A-673 whole cell lysate 20 μg
Lane 2: PANC-1 whole cell lysate 20 μg
Lane 3: HDLM-2 whole cell lysate 20 μg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 142 kDa
Observed MW: 135-150 kDa

WB result of AMBRA1 Recombinant Rabbit mAb
Primary antibody: AMBRA1 Recombinant Rabbit mAb at 1/1000 dilution
Lane 1: COS-7 whole cell lysate 20 μg
Secondary antibody: Goat Anti-Rabbit IgG (H+L), HRP conjugated at 1/10000 dilution
Predicted MW: 142 kDa
Observed MW: 135-150 kDa